CLOSE X
Mutual Fund
more from Mutual Fund
HomeMarketsMutual Fund MF UpdatesFund Card

Fund Card

GO

SBI Healthcare Opp Fund-Reg(G)

very highequitypharma & health care
431.47 -0.01(0.00%) NAV as on 25 Nov 2025
-1.46 % 1 M
1.87 % 1 Y
23.84 % 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

To provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

1.93

As on 31 Oct, 2025
age-icon Age :

26 yrs 4 m

Since 14 07 ,1999
exit_load Exit Load :

0.5%

aum AUM :

4,082.13 Crs

lock_in Lock-in :

0.50% on or before 15D, Nil after 15D

investing_style Investing Style :

Large Growth

Portfolio_book_value Portfolio Price To Book Value :

8.16

Min_Investment Min. Investment :

SIP 500 & Lumpsum 5000

Scheme_benchmark Scheme Benchmark :

NA

Fund_manager Fund Manager :

Tanmaya Desai

LATEST ASSET & PORTFOLIO ALLOCATION

as on Oct 31 ,2025
Debt 0.07 %
Others 3.86 %
Equity 96.07 %

TOP HOLDINGS

Sun Pharmaceutical Industries...11.18 %
Divi's Laboratories Ltd.7.26 %
Max Healthcare Institute Ltd.5.62 %
Cipla Ltd.4.41 %
Lonza Group4.05 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs64.15
Hospital & Healthcare Services21.41
Medical Equipment/Supplies/Accessories2.94
Chemicals2.58
Retailing0.93
See All Sectors

5-YEARS HISTORY

Financial Year2020-20212021-20222022-20232023-20242024-2025
NAV in Rs (as on 31-Mar-2025)252.90286.90281.32444.33532.43
Net Assets(Rs Crores) (as on 31-Mar-2025) 1563.95 1778.29 1589.27 2626.34 3610.51
Scheme Returns(%)(Absolute)73.5112.48-1.8658.8818.76
B'mark Returns(%)(Absolute)NANANANANA
Category Rank39/7548/7557/7614/904/102

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

SBI Healthcare Opp Fund-Reg(G)Very HighEquity431.47-0.01(0.00%)NAV As on 25 Nov, 202514-Jul-1999Inception Date4,082.13AUM In Cr.1.87%1Y23.84%3Y18.88%5Y16.06%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity40.110.21(0.53%)NAV As on 25 Nov, 202513-Jul-2018Inception Date6,437.36AUM In Cr.5.36%1Y26.93%3Y20.05%5Y20.72%Since Inception
Nippon India Pharma Fund(G)Very HighEquity514.771.33(0.26%)NAV As on 25 Nov, 202505-Jun-2004Inception Date8,346.49AUM In Cr.0.84%1Y21.35%3Y17.19%5Y20.13%Since Inception
corporate OFFICE Jhaveri Securities301/302 Payal Tower-II,Opp. M. S. University, Sayajigunj, Vadodara 390020.
CALL US 91-265-6161200/7161200
EMAIL US info@jhaveritrade.com
SEBI Reg. No. NSE, BSE, MCX : INZ000199232 Membership No.: NSE:08232, BSE:3015, MCX:56465 SEBI Regn.No. of DP : IN-DP-195-2016 (NSDL DPID:IN301991) AMFI: ARN-A3524 CIN of JSL: U67120GJ1992PLC018194 | GST : 24AAACJ4727A2Z4
COMPLIANCE OFFICER OFFICE
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors
© CopyRights 2022, Jhaveri Securities All rights reserved.
Designed & Developed by Accord Fintech Pvt Ltd.